Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 known ✓ | P00918 | 11/20 | 0.41 |
| ▸ | CA1 known ✓ | P00915 | 5/20 | 0.41 |
| ▸ | CA12 known ✓ | O43570 | 5/20 | 0.41 |
| ▸ | CA4 known ✓ | P22748 | 3/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 5/20 | 0.41 |
| ▸ | CA6 | P23280 | 2/20 | 0.41 |
| ▸ | CA5A | P35218 | 2/20 | 0.41 |
| ▸ | CA7 | P43166 | 2/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.41 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.41 |
| ▸ | F2 | P00734 | 2/20 | 0.39 |
| ▸ | TMPRSS4 | Q9NRS4 | 2/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | HTR6 | P50406 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5368249 | 0.88 | CA2 (0.43) | TDP1CA2CA1CA12CA9 | |
| SCHEMBL8083823 | 0.82 | HTR6 (0.53) | TDP1CA2CA1CA12CA9 | |
| SCHEMBL2881343 | 0.82 | TRPA1 (0.40) | TDP1CA2CA1CA12CA9 | |
| SCHEMBL1919298 | 0.78 | CA2 (0.67) | CA2CA1CA12CA9CA4 | |
| SCHEMBL1738692 | 0.78 | ENPP2 (0.46) | TDP1CA2CA1CA12CA9 | |
| SCHEMBL7772184 | 0.78 | F2 (0.64) | TDP1CA2CA1CA12CA9 | |
| SCHEMBL314445 | 0.78 | LMNA (0.48) | TDP1CA2CA1CA12CA9 | |
| SCHEMBL313925 | 0.78 | ALDH1A1 (0.44) | TDP1CA2CA1CA12CA9 | |
| SCHEMBL30968190 | 0.78 | LMNA (0.48) | TDP1CA2CA1CA12CA9 | |
| SCHEMBL4101241 | 0.78 | CA2 (0.67) | TDP1CA2CA1CA12CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118289795-A | Surface modified barite powder and preparation method and application thereof | 旬阳市健平矿业有限公司 | 2024-07-05 | — | — | CN | claimed |
| CN-108483975-B | High-performance asphalt warm-mixing agent | 辽宁仁泰交通科技有限公司 | 2020-12-15 | — | — | CN | claimed |
| US-9505713-B2 | High-purity sodium p-styrenesulfonate with excellent hue, method for producing the same, poly(sodium p-styrenesulfonate) with excellent hue using the same, and dispersant and synthetic starch for clothing finishing using the poly(sodium p-styrenesulfonate) | TOSOH ORGANIC CHEMICAL CO., LTD (JP) | 2016-11-29 | — | — | US | claimed |
| US-20150246876-A1 | HIGH-PURITY SODIUM P-STYRENESULFONATE WITH EXCELLENT HUE, METHOD FOR PRODUCING THE SAME, POLY (SODIUM P-STYRENESULFONATE) WITH EXCELLENT HUE USING THE SAME, AND DISPERSANT AND SYNTHETIC STARCH FOR CLOTHING FINISHING USING THE POLY ( SODIUM P-STYRENESULFONATE) | TOSOH ORGANIC CHEMICAL CO., LTD. (JP) | 2015-09-03 | — | — | US | claimed |
| US-20250092171-A1 | HIGH-PURITY 4-(2-BROMOETHYL)BENZENESULFONIC ACID, HIGH-PURITY STYRENESULFONIC ACID COMPOUND DERIVED THEREFROM, AND POLYMER THEREOF, AND METHODS FOR PRODUCING SAME | TOSOH FINECHEM CORPORATION (JP) | 2025-03-20 | — | — | US | disclosed |
| WO-2024203772-A1 | METHOD FOR PRODUCING ALPHA-CYANOACRYLATE | 東亞合成株式会社 | 2024-10-03 | — | — | WO | disclosed |
| CN-118289795-A | Surface modified barite powder and preparation method and application thereof | 旬阳市健平矿业有限公司 | 2024-07-05 | — | — | CN | disclosed |
| US-20240167922-A1 | TRANSPARENTIZING REAGENT AND TRANSPARENTIZING METHOD | KYOTO UNIVERSITY (JP) | 2024-05-23 | — | — | US | disclosed |
| CN-117209760-B | Sulfonated benzimidazole polymer and preparation method and application thereof | 国家电投集团氢能科技发展有限公司 | 2024-03-12 | — | — | CN | disclosed |
| EP-4306927-A1 | TRANSPARENTIZING REAGENT AND TRANSPARENTIZING METHOD | Kyoto University (JP) | 2024-01-17 | — | — | EP | disclosed |
| CN-117209760-A | Sulfonated benzimidazole polymer and preparation method and application thereof | 国家电投集团氢能科技发展有限公司 | 2023-12-12 | — | — | CN | disclosed |
| WO-2023171597-A1 | HIGH-PURITY 4-(2-BROMOETHYL)BENZENESULFONIC ACID, HIGH-PURITY STYRENESULFONIC ACIDS DERIVED THEREFROM AND POLYMERS THEREOF, AND METHODS FOR PRODUCING SAME | 東ソー・ファインケム株式会社 | 2023-09-14 | — | — | WO | disclosed |
| CN-108483975-B | High-performance asphalt warm-mixing agent | 辽宁仁泰交通科技有限公司 | 2020-12-15 | — | — | CN | disclosed |
| CN-111302979-A | Single-component molecular glass and preparation method and application thereof | 苏州瑞红电子化学品有限公司 | 2020-06-19 | — | — | CN | disclosed |
| US-9505713-B2 | High-purity sodium p-styrenesulfonate with excellent hue, method for producing the same, poly(sodium p-styrenesulfonate) with excellent hue using the same, and dispersant and synthetic starch for clothing finishing using the poly(sodium p-styrenesulfonate) | TOSOH ORGANIC CHEMICAL CO., LTD (JP) | 2016-11-29 | — | — | US | disclosed |
| US-20150246876-A1 | HIGH-PURITY SODIUM P-STYRENESULFONATE WITH EXCELLENT HUE, METHOD FOR PRODUCING THE SAME, POLY (SODIUM P-STYRENESULFONATE) WITH EXCELLENT HUE USING THE SAME, AND DISPERSANT AND SYNTHETIC STARCH FOR CLOTHING FINISHING USING THE POLY ( SODIUM P-STYRENESULFONATE) | TOSOH ORGANIC CHEMICAL CO., LTD. (JP) | 2015-09-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240167922-A1 | TRANSPARENTIZING REAGENT AND TRANSPARENTIZING METHOD | TST, TTR, ALB | CA2 2629/4885CA1 377/4885CA12 79/4885 |
| US-20150246876-A1 | HIGH-PURITY SODIUM P-STYRENESULFONATE WITH EXCELLENT HUE, METHOD FOR PRODUCING THE SAME, POLY (SODIUM P-STYRENESULFONATE) WITH EXCELLENT HUE USING THE SAME, AND DISPERSANT AND SYNTHETIC STARCH FOR CLOTHING FINISHING USING THE POLY ( SODIUM P-STYRENESULFONATE) | HPSE, STS, TST | CA2 3515/4885CA1 4090/4885CA12 3568/4885 |
| US-20250092171-A1 | HIGH-PURITY 4-(2-BROMOETHYL)BENZENESULFONIC ACID, HIGH-PURITY STYRENESULFONIC ACID COMPOUND DERIVED THEREFROM, AND POLYMER THEREOF, AND METHODS FOR PRODUCING SAME | BRPF1, WEE2, WEE1 | CA2 4639/4885CA1 4151/4885CA12 3652/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.